S-SPOT REF 777, 777S Adhere to skin for marking and identifying moles in mammography.

FDA Device Recall #Z-2831-2018 — Class II — June 13, 2018

Recall Summary

Recall Number Z-2831-2018
Classification Class II — Moderate risk
Date Initiated June 13, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Beekley Corporation
Location Bristol, CT
Product Type Devices
Quantity 3,384,024 pieces in total.

Product Description

S-SPOT REF 777, 777S Adhere to skin for marking and identifying moles in mammography.

Reason for Recall

There is a potential for imaging artifact to mimic calcifications on patient's mammograms

Distribution Pattern

Worldwide Distribution: US (Nationwide) and countries of; AUSTRALIA, AUSTRIA, BAHRAIN, CANADA, GREAT BRITAIN, ISRAEL, SAUDI ARABIA, SOUTH AFRICA & UNITED ARAB EMIRATES.

Lot / Code Information

REF 777 - Lot Numbers: 02281802 05301801 04041801 04211801 03301801 05101802 05241801 02191801 03151801 03281801 04281801 02131802 REF 777S - Lot Numbers

Other Recalls from Beekley Corporation

Recall # Classification Product Date
Z-2832-2018 Class II TomoSPOT REF 782, 782S, 783, 783S, 784, 784S, 7... Jun 13, 2018
Z-2830-2018 Class II O-SPOT REF 791, 791S Adhere to skin for mar... Jun 13, 2018
Z-2309-2017 Class III Beekley Medical 0-SPOT Mammography Skin Markers... May 8, 2017
Z-1787-2014 Class III Beekley Spots Light Image O-Spots for Mammograp... Jun 19, 2013
Z-2112-2012 Class II Beekley Altus Floral Skin Markers -Order Number... Jul 9, 2012

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.